Royal Bank of Canada
NUVB icon

Royal Bank of Canada’s Nuvation Bio NUVB Stock Holding History

Royal Bank of Canada’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20K Sell
4,654
-7,682
-62% -$42.8K ﹤0.01% 5901
2025
Q4 		$111K Sell
12,336
-249,326
-95% -$1.54M ﹤0.01% 5141
2025
Q3 		$968K Sell
261,662
-364
-0.1% -$992 ﹤0.01% 4015
2025
Q2 		$511K Buy
262,026
+250,387
+2,151% +$522K ﹤0.01% 4450
2025
Q1 		$20K Sell
11,639
-12,579
-52% -$28.6K ﹤0.01% 5928
2024
Q4 		$65K Sell
24,218
-1,290
-5% -$3.32K ﹤0.01% 5560
2024
Q3 		$58K Buy
25,508
+8,627
+51% +$26.3K ﹤0.01% 5628
2024
Q2 		$49K Sell
16,881
-3,645
-18% -$11.1K ﹤0.01% 5669
2024
Q1 		$75K Sell
20,526
-46,369
-69% -$89K ﹤0.01% 5350
2023
Q4 		$101K Buy
66,895
+42,392
+173% +$54.6K ﹤0.01% 5612
2023
Q3 		$33K Buy
24,503
+9,304
+61% +$15.5K ﹤0.01% 5989
2023
Q2 		$27K Buy
15,199
+8,687
+133% +$14.8K ﹤0.01% 6060
2023
Q1 		$11K Sell
6,512
-8,263
-56% -$16.7K ﹤0.01% 6269
2022
Q4 		$28K Buy
14,775
+13,247
+867% +$26.8K ﹤0.01% 6164
2022
Q3 		$3K Buy
1,528
+860
+129% +$2.46K ﹤0.01% 6908
2022
Q2 		$2K Sell
668
-9,111
-93% -$39.7K ﹤0.01% 6978
2022
Q1 		$51K Sell
9,779
-22,875
-70% -$129K ﹤0.01% 6078
2021
Q4 		$277K Buy
32,654
+25,367
+348% +$233K ﹤0.01% 5014
2021
Q3 		$73K Buy
7,287
+3,161
+77% +$28.7K ﹤0.01% 5928
2021
Q2 		$39K Buy
+4,126
New +$47K ﹤0.01% 6202

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada's NUVB Position: Q1 2026 in Review

Royal Bank of Canada reduced its Nuvation Bio (NUVB) stake by 62% in Q1 2026, selling an estimated $42.8K and leaving 4,654 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #5901.

Royal Bank of Canada first reported a position in NUVB in Q2 2021 and has held it in 20 quarters since. The position peaked at $968K in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Royal Bank of Canada held 4,654 shares of Nuvation Bio worth $20K as of Q1 2026.
  • Royal Bank of Canada sold 7,682 Nuvation Bio shares in Q1 2026, an estimated $42.8K.
  • Nuvation Bio made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5901 holding.
  • Royal Bank of Canada first reported a position in Nuvation Bio in Q2 2021 and has held it in 20 quarters since.
  • Royal Bank of Canada's Nuvation Bio position peaked at $968K in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.